they signal a structural shift in how obesity can be treated, prescribed and scaled
The patent for semaglutide, the active ingredient in Novo Nordisk's weight-loss drugs Wegovy and Ozempic, expired in India in March, and by the end of 2026, it will expire in 10 countries, including Brazil, China, South Africa, Turkey, and Canada
Compounded tirzepatide typically comes in multi-dose vials requiring you to draw each dose with a syringe, track remaining medication volume, and properly dispose of needles
For most people, the symptom goes away on its own, but if it continues or gets worse, talk to your doctor
Gastroenterology 2005
If youre on a GLP-1, or just trying to find answers, I hope this helped